Form 4 · EMR
Emerson Senior VP & CCO Lisa Flavin reports an award of 18,515 shares
Part of a grouped insider digest: see all related filings with totals →
Lisa Flavin, Emerson's Senior VP & CCO, filed a Form 4 on Nov 4, 2026 at 4:40 PM ET reporting transactions between Nov 2, 2026 and Nov 3, 2026.
The filing reports 18,515 shares in a grant or award (code A); and 11,362 shares withheld to pay the exercise price or tax (code F).
After these transactions, the filing lists 103,701 shares held directly.
Effect on holdings
Taken together, the rows reported here raised Lisa Flavin's directly held shares by 7.4%, from 96,548 to 103,701.
Reporting person
- Lisa Flavin, Senior VP & CCO (as filed: Flavin Lisa)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | F | Common Stock | 4,406 | $167.95 | Disposed | 92,142 | Direct |
| 2026-11-02 | A | Common Stock | 14,087 | Acquired | 106,229 | Direct | |
| 2026-11-02 | F | Common Stock | 6,206 | $167.95 | Disposed | 100,023 | Direct |
| 2026-11-02 | A | Common Stock | 4,428 | Acquired | 104,451 | Direct | |
| 2026-11-03 | F | Common Stock | 750 | $166.43 | Disposed | 103,701 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 4, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Emerson company file → · More Emerson filings
Disclosures
- Editor holdings in EMR
- The editor holds no position in Emerson (EMR). As of Nov 11, 2026.
- Last updated
- Nov 4, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold EMR.